Impact of the new clinical breaking points proposed by the clinical and laboratory standards institute (CLSI) in the antifungal susceptibility profile of clinical strains isolated from invasive bloodstream Candida spp. infections in Spain

  1. Cisterna, R.
  2. Tellería, O.
  3. Hernaez, S.
  4. Ezpeleta, G.
Zeitschrift:
Clinical Medicine Insights: Therapeutics

ISSN: 1179-559X 1179-559X

Datum der Publikation: 2012

Ausgabe: 4

Seiten: 19-27

Art: Artikel

DOI: 10.4137/CMT.S8293 GOOGLE SCHOLAR lock_openOpen Access editor

Ziele für nachhaltige Entwicklung